Matthew W. Foehr
Overview
Matthew W. Foehr received an average of $5M in total compensation, including $541K in salary, at OmniAb from 2021 to 2023. Matthew Foehr also received an average of $3M at Ligand Pharmaceuticals from 2011 to 2021.
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
OmniAbChief Executive Officer and Director
OmniAbChief Executive Officer and Director
OmniAbChief Executive Officer and Director
Ligand PharmaceuticalsPresident and Chief Operating Officer
Ligand PharmaceuticalsPresident and Chief Operating Officer
Ligand PharmaceuticalsPresident and Chief Operating Officer
Ligand PharmaceuticalsPresident and Chief Operating Officer
Ligand PharmaceuticalsPresident and Chief Operating Officer
Ligand PharmaceuticalsPresident and Chief Operating Officer
Ligand PharmaceuticalsPresident and Chief Operating Officer
Source: SEC filings on April 26, 2024, May 1, 2023, April 22, 2022, November 12, 2020, April 24, 2020, April 30, 2018, April 14, 2017, April 12, 2016, March 12, 2015, and April 21, 2014.
Related executives
We found nine more executives who work or worked at OmniAb and Ligand Pharmaceuticals.
Charles Berkman
OmniAb
Chief Legal Officer
Kurt Gustafson
OmniAb
Chief Financial Officer
John Higgins
Ligand Pharmaceuticals
Chief Executive Officer
Matthew Korenberg
Ligand Pharmaceuticals
Chief Financial Officer
Nishan de Silva
Ligand Pharmaceuticals
Chief Financial Officer
Melanie Herman
Ligand Pharmaceuticals
Chief Financial Officer
John Sharp
Ligand Pharmaceuticals
Chief Financial Officer
Martin Meglasson
Ligand Pharmaceuticals